Currently, generic and biosimilar drugs make up about 90% of prescriptions in the US, yet they account for only a small share of total drug costs. HealthDay News — The US Food and Drug Administration ...

The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax certain rules for approving low-cost versions of some high-priced medications, in an effort to speed up access to ...

Developers of biosimilars, medicines that are near-identical copies of biologic drugs, will no longer be required to conduct clinical trials to prove effectiveness. HealthDay News — The US Food and ...

The federal Food and Drug Administration today approved a new menopause drug that reduces hot flashes and night sweats after the drug was successfully tested at UVA Health and other sites in the ...

Officials say this will boost competition and lower drug prices for patients FRIDAY, Oct. 31, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) announced Wednesday that it will relax ...

Federal regulators will no longer require costly clinical trials for most biosimilars, speeding up approval The change could cut timelines in half and save drugmakers tens of millions in costs ...

The FDA approved Lynkuet, a new nonhormonal menopause drug that reduces moderate to severe hot flashes and night sweats.

Daniel Payne reports on how the health industry and Washington influence and impact each other. He joined STAT in 2025 after covering health care at POLITICO. You can reach Daniel on Signal at danielp ...

WASHINGTON — The Trump administration announced a draft framework Wednesday that officials say will speed cheaper versions of biologic drugs to market with the aim of making medicine more affordable ...

According to a recent study, 6 in 10 Americans reported taking at least one prescription medication, so it’s important to know how to take it properly. Dr. Cedrek McFadden, board-certified surgeon, ...